JP2013524792A5 - - Google Patents

Download PDF

Info

Publication number
JP2013524792A5
JP2013524792A5 JP2013505367A JP2013505367A JP2013524792A5 JP 2013524792 A5 JP2013524792 A5 JP 2013524792A5 JP 2013505367 A JP2013505367 A JP 2013505367A JP 2013505367 A JP2013505367 A JP 2013505367A JP 2013524792 A5 JP2013524792 A5 JP 2013524792A5
Authority
JP
Japan
Prior art keywords
nucleic acid
acid molecule
absent
nucleotides
nucleotide sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013505367A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013524792A (ja
JP5941904B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/002068 external-priority patent/WO2011131371A1/en
Publication of JP2013524792A publication Critical patent/JP2013524792A/ja
Publication of JP2013524792A5 publication Critical patent/JP2013524792A5/ja
Application granted granted Critical
Publication of JP5941904B2 publication Critical patent/JP5941904B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013505367A 2010-04-21 2011-04-21 脂質に結合する核酸 Expired - Fee Related JP5941904B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP10004253 2010-04-21
EP10004253.0 2010-04-21
EP11000117 2011-01-10
EP11000117.9 2011-01-10
PCT/EP2011/002068 WO2011131371A1 (en) 2010-04-21 2011-04-21 Lipid binding nucleic acids

Publications (3)

Publication Number Publication Date
JP2013524792A JP2013524792A (ja) 2013-06-20
JP2013524792A5 true JP2013524792A5 (https=) 2014-06-05
JP5941904B2 JP5941904B2 (ja) 2016-06-29

Family

ID=44201395

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013505367A Expired - Fee Related JP5941904B2 (ja) 2010-04-21 2011-04-21 脂質に結合する核酸

Country Status (5)

Country Link
US (1) US8871920B2 (https=)
EP (1) EP2561079A1 (https=)
JP (1) JP5941904B2 (https=)
CN (1) CN102906265B (https=)
WO (1) WO2011131371A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012206750A1 (en) 2011-01-10 2013-07-18 Noxxon Pharma Ag Nucleic acid molecule having binding affinity to a target molecule and a method for generating the same
EP2802659A1 (en) 2012-01-10 2014-11-19 Noxxon Pharma AG Nucleic acids specifically binding cgrp
WO2013104540A1 (en) 2012-01-10 2013-07-18 Noxxon Pharma Ag New c5a binding nucleic acids
US11583528B2 (en) 2016-02-17 2023-02-21 Children's Medical Center Corporation FFA1 (GPR40) as a therapeutic target for neural angiogenesis diseases or disorders
EP3264092A1 (en) 2016-07-01 2018-01-03 Centogene AG Use of lyso-gb1 as druggable target
JP7140848B2 (ja) 2018-05-17 2022-09-21 ザ プロクター アンド ギャンブル カンパニー 毛髪被覆率分析のためのシステム及び方法
US11172873B2 (en) 2018-05-17 2021-11-16 The Procter & Gamble Company Systems and methods for hair analysis
US20200000697A1 (en) * 2018-06-29 2020-01-02 The Procter & Gamble Company Aptamers for hair care applications
WO2020005326A1 (en) 2018-06-29 2020-01-02 The Procter & Gamble Company Aptamers for personal care applications
CN109402127B (zh) * 2018-09-29 2021-12-10 复旦大学附属眼耳鼻喉科医院 一组与结缔组织生长因子特异性结合的高亲和力核酸适配体及其应用
US11806419B2 (en) 2019-04-16 2023-11-07 The Procter & Gamble Company Aptamers for odor control applications
BR112021026559A2 (pt) * 2019-07-17 2022-02-15 Noxopharm Ltd Terapia imuno-oncológica usando compostos isoflavona
US12039732B2 (en) 2021-04-14 2024-07-16 The Procter & Gamble Company Digital imaging and learning systems and methods for analyzing pixel data of a scalp region of a users scalp to generate one or more user-specific scalp classifications

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011020A (en) 1990-06-11 2000-01-04 Nexstar Pharmaceuticals, Inc. Nucleic acid ligand complexes
US6225063B1 (en) 1998-05-22 2001-05-01 University Technology Corporation RNA channels in biological membranes
US6395029B1 (en) 1999-01-19 2002-05-28 The Children's Hospital Of Philadelphia Sustained delivery of polyionic bioactive agents
US6652886B2 (en) 2001-02-16 2003-11-25 Expression Genetics Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents
US7629456B2 (en) 2001-10-26 2009-12-08 Noxxon Pharma Ag Modified L-nucleic acid
EP1306382A1 (de) 2001-10-26 2003-05-02 Noxxon Pharma AG Modifizierte L-Nukleinsäure
WO2003070823A2 (en) 2002-02-20 2003-08-28 The General Hospital Corporation Conjugates comprising a biodegradable polymer and uses therefor
MXPA05011022A (es) 2003-04-13 2006-04-27 Enzon Pharmaceuticals Inc Profarmacos oligonucleotidos polimericos.
GB0314472D0 (en) 2003-06-20 2003-07-23 Warwick Effect Polymers Ltd Polymer
US20090281296A1 (en) 2004-02-09 2009-11-12 Supramol Parenteral Colloid Gmbh Process for the production of conjugates from polysaccharides and polynucelotides
MXPA06010782A (es) 2004-03-23 2007-03-28 Complex Biosystems Gmbh Ligador de profarmaco.
CN101098703B (zh) 2004-11-05 2011-08-03 费城儿童医院 用于分子治疗的生物降解连接剂
EP1877069A2 (de) 2005-05-04 2008-01-16 Noxxon Pharma AG Neue verwendung von spiegelmeren
US20090074720A1 (en) * 2005-10-28 2009-03-19 Sabbadini Roger A Methods for decreasing immune response and treating immune conditions
US7862812B2 (en) 2006-05-31 2011-01-04 Lpath, Inc. Methods for decreasing immune response and treating immune conditions
JP2010503707A (ja) 2006-09-15 2010-02-04 エンゾン ファーマスーティカルズ インコーポレイテッド オリゴヌクレオチドの送達を目的としたヒンダードエステル系生体分解性リンカー
WO2008052774A2 (en) 2006-10-31 2008-05-08 Noxxon Pharma Ag Methods for detection of a single- or double-stranded nucleic acid molecule

Similar Documents

Publication Publication Date Title
JP2013524792A5 (https=)
Martino et al. Longitudinal, genome-scale analysis of DNA methylation in twins from birth to 18 months of age reveals rapid epigenetic change in early life and pair-specific effects of discordance
Ripke et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia
JP2014533098A5 (https=)
JP2023153949A (ja) ヒトｅｚｈ２の阻害剤、およびその使用方法
JP2009543567A5 (https=)
JP2015509705A5 (https=)
JPWO2013073602A1 (ja) 標的タンパク質に結合する核酸断片
JP2013540423A5 (https=)
RU2014132708A (ru) НОВЫЕ СВЯЗЫВАЮЩИЕ C5a НУКЛЕИНОВЫЕ КИСЛОТЫ
ES2629183T3 (es) Aptámeros para diagnóstico de Clostridium difficile
RU2008136907A (ru) Нуклеиновые кислоты, связывающиеся с мср-1
JP2015506174A5 (https=)
JP2009526532A5 (https=)
Gupta et al. Impact of diet and host genetics on the murine intestinal mycobiome
Zhou et al. Fast and sensitive multivalent spatial pattern-recognition for circular RNA detection
DK3277835T3 (en) GENETIC PREDICTORS OF A REACTION ON TREATMENT WITH CRHR1 ANTAGONISTS
Chen et al. Functional characterization and clinical implication of a novel epidemic carbapenem-resistant Acinetobacter baumannii genetic marker
WO2018159750A1 (ja) オピオイド薬の治療有効性を予測するためのｍｉｃｒｏＲＮＡバイオマーカー
George Jr Recent genetic discoveries implicating ion channels in human cardiovascular diseases
CN102827935B (zh) 定量检测FIP1L1-PDGFRA融合基因mRNA水平的试剂盒
CN101892297B (zh) 高血压易感基因单核苷酸多态性位点的检测方法及其试剂盒
Sacharczuk et al. A polymorphism in exon 2 of the δ-opioid receptor affects nociception in response to specific agonists and antagonists in mice selectively bred for high and low analgesia
Zhang et al. Genotypic and phenotypic characteristics of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy from China
CN107385065B (zh) 扩增核酸的方法及其应用